CPK-850

N/A

Report date: 2023/10/26 16:14:38

Base Information

Drug NameCPK-850

Drug Alias NamescAAV8-pRLBP1(short)- hRLBP1 vectorCPK850 Gene TherapyscAAV8-RLBP1Recombinant adeno-associated virus 8 (AAV8) vector encoding the human RLBP1 gene（Novartis）CPK-850

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV8 vector

Mechanisms of ActionGene transference

TargetsNot applicable

Therapy Area/IndicationsRetinitis Pigmentosa

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySweden

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesNovartis Pharma Ag

China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag

Inactive CompaniesN/A

Active IndicationsRetinitis Pigmentosa

Inactive IndicationsN/A

Other Information

ATC CodeN/A